Instituut voor Neuropathische Pijn

Wij onderschrijven de gedragscode van de Health On the Net Foundation
Home
Research & Development
Drug development issues related to new compounds for treating neuropathic pain and neuropathy are presented here.
Filter     Sorteer op     Toont # 
Titel
Analgesic creams from the institute of neuropathic pain
PEA, Palmitoylethanolamide per os active in different animal models
Natrium channel disruption in small fibre neuropathy
Painkillers efficacy in 2010 less compared to 2005
Clinical Trials with Normast: overview
Syringomyelia in Cavalier spaniels treated succesfully with palmitoylethanolamide (Normast)
Parkinson's disease and modulation via endocannabinoids
Inflammatory bowel disease, mast cells and Normast
Metabolism and degradation of palmitoylethanolamide
Palmitoylethanolamide (Normast) as regulatory mechanism for the metabolism of mast cells
Mast cells and abdominal aneurysms
Mast cells , periapical inflammation, peridontitis and palmitoylethanolamide
Selected pharmacology of palmitoylethanolamide
Adenosine agonists and neuropathic pain
Palmitoylethanolamide and immune system: early studies
Fibromyalgia is linked to Inflammatory Back Pain
Antidepressants into low back pain: duloxetine (Cymbalta®)
Mast cells and nerve endings in the heart: clinical significance?
Il-17: new target in neuropathic pain
Fractalkine and neuropathic pain
Nanorobots interacting with neurons
Epoxygenated fatty acids (EFAs) and neuropathic pain
R-flurbiprofen reduces glutamate in neuropathic pain
Avigen AV411 as a glia modulator in neuropathic pain
Ibudilast, XT101 in neuropathic pain
NeurogesX to Qutenza® (capsaicin) 8% Patch in HIV-Associated Neuropathy
Migraine and mast cells
The search for the palmitoylethanolamide receptor
KU-32 in diabetic neuropathy
Statin-associated myalgia and myopathy
 
<< Begin < Vorige 1 2 3 4 Volgende > Einde >>
Resultaten 1 - 30 van 99
© Copyright 2012 Instituut voor Neuropathische Pijn. Alle rechten voorbehouden.